Title : Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells.

Pub. Date : 2022 May 24

PMID : 35604090






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mechanically, bilirubin inhibited sorafenib-induced activation of GSK-3beta and subsequent downstream MCL-1 degradation. Sorafenib glycogen synthase kinase 3 alpha Homo sapiens